Key Takeaways:
- CME Group's Q1 earnings missed estimates slightly, impacting share prices.
- Analysts maintain a "Hold" rating with a modest price target upside.
- GuruFocus' GF Value indicates a potential downside compared to current trading levels.
CME Group (CME, Financial) shares experienced a 1.4% decline in premarket trading after the derivatives exchange reported first-quarter earnings that narrowly missed analysts' expectations, despite achieving record trading volumes. The adjusted EPS reported was $2.80, just shy of the anticipated $2.81. Revenue also saw an increase to $1.64 billion, although it fell short of the $1.66 billion forecast.
Wall Street Analysts' Insights
According to the one-year price targets provided by 15 analysts, the average target price for CME Group Inc (CME, Financial) stands at $272.07, with estimates ranging from a high of $301.00 to a low of $219.00. This average target suggests a potential upside of 2.45% from the current share price of $265.56. For a deeper dive into these estimates, visit the CME Group Inc (CME) Forecast page.
The consensus from 18 brokerage firms currently classifies CME Group Inc's (CME, Financial) stock with an average recommendation rating of 2.6, equating to a "Hold" status. This rating falls on a scale from 1 to 5, where 1 represents a Strong Buy and 5 suggests a Sell.
Evaluating CME Group's Valuation
According to estimates from GuruFocus, the projected GF Value for CME Group Inc (CME, Financial) over the next year is calculated to be $252.58. This figure indicates a potential downside of 4.89% from the current trading price of $265.56. The GF Value represents an estimate of the fair market value, derived from historical stock multiples, business growth history, and future performance projections. For comprehensive data analysis, explore the CME Group Inc (CME) Summary page.
